Tuesday 22 October 2019

Reuters Health Report: Biogen to seek U.S. approval for Alzheimer's drug; shares jump 21%

Reuters.com Newsletter

Biogen to seek U.S. approval for Alzheimer's drug; shares jump 21%

Biogen Inc is planning to file for U.S. regulatory approval for its Alzheimer's treatment aducanumab after fresh analysis of its clinical trial showed promise, the drugmaker said on Tuesday, sending its shares up 21% before the bell.

HIV-positive British living in Spain could lose healthcare post-Brexit

(Reuters Health) - British citizens with HIV who live in Spain could face serious healthcare challenges in the event of a no-deal Brexit, potentially risking public health at large, researchers say.

Kenya launches first breast milk bank to help newborns

The five mothers sat in a bright blue room in Kenya's largest maternity hospital waiting to pump breast milk - but not for their own newborns.

Drugstore drones: UPS will fly CVS prescriptions to U.S. customers

United Parcel Service Inc's new Flight Forward drone unit will soon start home prescription delivery from CVS Health Corp .

Drug firms avert landmark opioid trial as talks on $48-billion settlement set to resume

Four large drug companies could resume talks on Tuesday to try to reach a $48 billion settlement of all opioid litigation against them, after agreeing with two Ohio counties to a $260 million deal to avert the first federal trial over their role in the U.S. opioid epidemic.

October brings losses for short sellers in U.S. opioid-related shares

October has been a rough month for short sellers betting against companies at the heart of the opioid crisis, although those traders still have paper profits of almost $600 million for the year, according to data from financial analytics firm S3 Partners.

Vertex prices cystic fibrosis combo treatment at $311,000-per-year

Vertex Pharmaceuticals Inc has priced its three-drug combination for cystic fibrosis (CF) at $311,503 per year, after winning early U.S. approval on Monday.

Massachusetts vaping sales ban can stand but needs fixes: judge

A Massachusetts judge on Monday declined to immediately halt a ban on the sale of vaping products adopted after an outbreak of e-cigarette-related lung injuries, but he said the state must redo the ban and get public comment this time.

Factbox: Billion-dollar lawsuits accuse drugmakers, distributors of fueling U.S. opioid crisis

On Monday, two Ohio counties reached a last-minute settlement with four companies they accused of fueling the nationwide opioid epidemic. The counties were seeking billions of dollars to cover the cost of addiction treatment programs, healthcare and other services.

Factbox: The U.S. opioid epidemic by the numbers

Opioid deaths in the United States have soared over the last two decades, driving a wave of litigation against drugmakers and distributors.

Movement during class improves students' academic abilities

(Reuters Health) - When academic classes include physical activity, like squats or running in place, students do better on tests, a new study suggests.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS